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Postoperative drainageRhBMP-2 is a bone fusion enhancer commonly used in scoliosis reconstruction surgery. It is delivered
via an absorbable collagen sponge but has been known to migrate away from its delivery site. RhBMP-2
extravasation in surgical drainage has been noted during ﬁrst two days post-surgery. Cell savers are widely
used in scoliosis reconstruction to limit transfusion requirements and are commonly deployed in cases where
rhBMP-2 is used for fusion augmentation. It is not known whether rhBMP-2 is present in salvaged blood or
ﬁltered away during cell saver recycling. Through this case series of four patients who underwent scoliosis
reconstruction, we assess cell saver efﬁcacy in ﬁltering rhBMP-2 molecules by quantifying the amount of
rhBMP-2 present in salvaged blood obtained after postoperative drainage recycling by OrthoPAT® cell saver
and comparing it to rhBMP-2 leakage in postoperative drainage without cell saver recycling. We report an
almost 10-fold reduction of rhBMP-2 concentration in salvaged blood obtained after cell saver recycling of
postoperative drainage, suggesting cell saver effectiveness in ﬁltering rhBMP-2 molecules.d and Reconstructive Surgery
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Recombinant bone morphogenetic protein-2 (rhBMP-2) is a
potent bone inducer that has been extensively used in spinal surgery
to augment fusion and prevent pseudoarthrosis. FDA approval
remains limited to single level anterior lumbar body fusion surgery,
however successful results have extended rhBMP-2’s off-label usage
to numerous spine surgery procedures including multilevel degener-
ative scoliosis reconstruction with excellent results [1]. To improve
osteoinductive potency, rhBMP-2 is delivered intraoperatively via an
absorbable collagen sponge (ACS), which increases retention at the
fusion site [2]. There are however concerns of rhBMP-2 leakage from
the sponge. Results of previous in-vitro and animal studies indicate
that a large percentage of implanted rhBMP-2 is released from thesponge during the ﬁrst 48 h after surgery [3,4]. It is also during the
ﬁrst two postoperative days (POD) that rhBMP-2 extravasation in
surgical drainage was noted after posterolateral fusion surgery [5].
Cell salvage techniques are commonly employed in spinal surgery
to salvage patient’s red blood cells (RBCs) and reduce transfusion
requirements. Blood is salvaged from operative ﬁeld or less commonly
from postoperative drainage. Considering evidence of rhBMP-2
extravasation in surgical drainage and likely leakage into operative
ﬁeld, autologous transfusion using intra or postoperative cell salvage
may inadvertently introduce rhBMP-2 molecules into systemic circula-
tion. It is therefore clinically relevant to knowwhether cell saver devices
act as effectiveﬁlters of rhBMP-2, reducing its concentration in salvaged
blood destined for systemic circulation.
In this series we discuss four cases that underwent rhBMP-2
augmented degenerative scoliosis reconstruction. RhBMP-2 recovery
was prospectively measured in postoperative drainage and in salvaged
blood after drain contents underwent cell saver processing. Our aimwas
to investigate cell saver efﬁcacy in ﬁltering rhBMP-2 molecules by
quantifying the amount of rhBMP-2 present in salvaged blood derived
after postop drainage recycling by cell saver and comparing it to
rhBMP-2 leakage in drainage without cell saver recycling.
Methods
Four patients (A, B, C and D) that underwent degenerative scoliosis
reconstructionusing rhBMP-2containing INFUSE®BoneGraft (Medtronic
Spinal and Biologics, Memphis, TN) were studied (Table 1). For each case
Table 1
Surgical information for patients A, B, C and D.
Patient Age, yrs Study Aim Surgery Total BMP usage, mg Total drain output, mL Salvaged blood, mL
A1 58 Initial ‘discovery’ of BMP-2 drain leakage T3–iliac PSF, L4–5 TLIF 16.2 2580 NA
B2 65 Daily trend of BMP-2 drain leakage T2–iliac PSF, L4–5, L5–S1 TLIF 12.0 2860 NA
C3 68 Daily trend of BMP-2 leakage in salvaged blood T6–S1 PSF, L4–5, L5–S1 TLIF 12.0 2500 870
D3 71 Daily trend of BMP-2 leakage in salvaged blood T10–iliac PSF, L3–4, L4–5, L5–S1 TLIF 12.0 1505 225
1 Patient A: Single drainage sample analyzed on postoperative day (POD) 4.
2 Patient B: Serial analysis performed on postoperative drainage. Final drain removal POD 10.
3 Patients C & D: Serial analysis performed on salvaged blood obtained after cell saver processing of postop drainage.
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Routineclosurewasperformedover twoRedivacsuctiondrainsplaceddeep
to the fascia. Postoperative recovery in all four patients was unremarkable
with good functional outcomes noted at follow-up.
Patients A and B were essentially the ‘control’ cases in our series.
For patient A 16.2 mg of rhBMP-2 was used during the procedure and
only a single drainage sample (500 mL) taken on POD 4 was sent
for rhBMP-2 analysis. Since this was the ﬁrst case in our series,
our main aim was to ‘discover’ whether rhBMP-2 extravasates in
surgical drainage. For patient B 12 mg of rhBMP-2 was used during
surgery. For this case however a more robust charting and analysis of
postoperative drainage were carried out. Drain output was closely
monitored and drains were clamped once total output reached
300 mL for the day and were unclamped the following day. Each day
the drain bottles were changed and the bottles containing the
preceding day’s output were sent for rhBMP-2 analysis. BMP-2
leakage trending was performed till POD 10 after which the surgical
drains were removed.
For patient’s C and D, 12 mg of rhBMP-2 was delivered during
surgery. Post surgery the drains were connected to an OrthoPAT®
cell saver (Orthopaedic Perioperative Autotransfusion System,
Haemonetics Corporation, Braintree, MA) (Image 1). Portability of
OrthoPAT® cell saver enabled the device to be linked to the drains
even in the wards. Blood was salvaged daily from the drains and sent
for rhBMP-2 analysis the same day.
The concentration of rhBMP-2 in postoperative drainage sample
and salvaged blood was determined by enzyme-linked immunosor-
bent assay ELISA (Quantikine BMP-2, R&D Systems,Minneapolis, MN).
A standard curve using serial dilutions of known concentration of
rhBMP-2 (INFUSE, provided by Medtronic) in buffer was derived for
each trial of ELISA as described in the product insert. The total leaked
amount (mg) of rhBMP-2 was calculated from the concentration and
volume. The leaked proportion (%) was calculated based on the initial
amount used.Fig. 1. Concentration of rhBMP-2 in postop drainage (patients A & B) and salvaged
blood (patients C & D). Mean concentration of rhBMP-2 in drainage in patient B was
93.25 ng/mL (range 85–100). Mean concentrations in salvaged blood in patients C and
Dwere 3.72 ng/mL (range 3.57–3.94) and 9.36 ng/mL (range 5.68–14.47), respectively.Results
RhBMP-2 in postoperative drainage (patients A & B)
In patient A, 100 μg of rhBMP-2 at a concentration of 200 ng/mL
was recovered from 500 mL of postoperative drainage on POD 4. Only
a single sample was taken and no trending was performed. This
represented 0.63% of the total amount implant. For patient B serial
analysis of postoperative drainage showed rhBMP-2 leakage during
the ﬁrst four postoperative days. 136 μg of rhBMP-2 at an average
concentration of 93.25 ng/mL leaked out during the ﬁrst four days,
representing 1.13% of the initial implanted amount (Table 2a). No
rhBMP-2 was detected after POD 4.
RhBMP-2 in salvaged blood (patients C & D)
Compared to rhBMP-2 concentration in postoperative drainage in
patients A & B, much lower concentrations (10-fold reduction) were
detected in salvaged blood obtained after OrthoPAT® processing of
postoperative drainage frompatients C &D (Fig. 1). For patient C, 1.3 μg,
1.8 μg&0.14 μgof rhBMP-2weredetected in salvagedbloodonPOD1, 2
& 3 respectively, at an average concentration of 3.72 ng/mL. Total
leakage proportion was 0.02%. In patient D, 1.2 μg, 0.7 μg and 0.01 μgImage 1. Surgical drain connected to an OrthoPAT® cell saver.
Table 2a
RhBMP-2 leakage in postoperative drainage for patients A and B.
Patient Total BMP
usage, mg
BMP leak
POD 1, μg
BMP leak
POD 2, μg
BMP leak
POD 3, μg
BMP leak
POD 4, μg
BMP leak
POD 5, μg
Mean BMP
concentration, ng/mL
Total BMP leak, μg Leak
proportion3, %
A1 16.2 100 200 0.69
B2 12 38.5 31.2 30.1 36.2 nil 93.25 136 1.13
1 Patient A: Single drainage sample analyzed on postoperative day (POD) 4.
2 Patient B: Serial analysis performed on postop drainage (no BMP detected after POD 4). Final drain removal POD 10.
3 Leakage proportion (total leaked amount/total BMP used) × 100.
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and 3 (overall leakage proportion 0.01%). Mean concentration was
9.36 ng/mL (Table 2b).
Discussion
Cell Savers are widely used in spine surgery despite controversy
regarding overall beneﬁt [6,7]. The OrthoPAT® perioperative auto
transfusion system is a cell saver designed speciﬁcally for use in
orthopaedic procedures with signiﬁcant blood loss such as joint
replacement and spinal fusion. Red blood cells (RBC) are separated
fromwaste products by centrifugation during both intraoperative and
postoperative processing; they are then washed and re-concentrated
for greater purity [8]. Portability of OrthoPAT® cell saver enables the
device to be linked to the drains even in the wards.
Cell savers are deployed even in cases where rhBMP-2 is used for
fusion augmentation. Mok et al. reported rhBMP-2 drain extravasation
in a series of 9 cases of posterolateral fusion [5]. An average of 68 μg of
BMP-2 (range, 13–498) was recovered from drains, representing 0.58%
(range, 0.21%–4.2%) of the implanted amount. For our ‘control’ case
(patient B) 135 μg of rhBMP-2 was recovered during the ﬁrst four days
after surgery, representing 1.13% of the total implanted amount. Results
from our report complement the report of Mok et al. in demonstrating
rhBMP-2 extravasation into surrounding ﬁeld and eventually into
postop drains. Perioperative cell savage in this situation may lead to
inadvertent systemic introduction of rhBMP-2. BMP-2 is inherently a
proinﬂammatory molecule and systemic introduction may pose
concerns. In rat models rhBMP-2 has shown to stimulate inﬂammatory
cytokine production levels, with a dose dependent release of proin-
ﬂammatory cytokines such at IL6, IL10 and TNF alpha [9].
Our study on patients C and D was to assess cell saver efﬁcacy in
ﬁltering BMP. RhBMP-2 was still detectable in salvaged blood after
drain contents underwent OrthoPAT® processing, though concentra-
tion was greatly reduced (10-fold reduction) when compared to
rhBMP-2 recovery in patient B. The reduced rhBMP-2 concentration in
salvaged blood could be attributed to OrthoPAT® processing. The
molecules are either ﬁltered away during centrifugation or degraded
during RBC washing. Overall the reduced concentrations in salvaged
blood do indicate cell saver efﬁcacy in ﬁltering rhBMP-2.Table 2b
RhBMP-2 detection in postoperative salvaged blood for patients C and D.
Patient Total BMP
usage, mg
BMP in salvage
blood, POD 1, μg
BMP in salvage
blood, POD 2, μg
BMP in salvage
blood, POD 3, μg
BMP in
blood,
C1 12 1.30 1.8 0.14 nil
D1 12 1.20 0.7 0.01 nil
1 Patients C & D: Serial analysis performed on salvaged blood obtained after cell saver pr
2 Leakage proportion (total leaked amount/total BMP used) × 100.In our detection of rhBMP-2 in surgical drainage we have
demonstrated BMP migration from the initial delivery site to
operative ﬁeld and drains. We have also demonstrated cell saver
efﬁcacy in ﬁltering rhBMP-2 by noting reduced concentrations of
rhBMP-2 in blood salvaged from postop drains.
Though our results appear to suggest minimal risk of rhBMP-2’s
systemic introduction due to cell saver ﬁltering, our conclusions are
limited by the small sample size and the fact that were only able to
analyze postop salvaged blood for rhBMP-2 presence. Intraoperative
cell salvage is the more commonly deployed method of perioperative
auto-transfusion and therefore rhBMP-2 analysis of blood recycled
from operative ﬁeld should be included in future projects. Further
research is suggested to ascertain the true clinical application of cell
saver ﬁltration of rhBMP-2 and the overall safety of perioperative
transfusion in these cases.References
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